The Food and Drug Administration on Tuesday approved Novo Nordisk's Ozempic to treat chronic kidney disease in patients who also have Type 2 diabetes, expanding the use of the wildly popular ...

Novo Nordisk said the Food and Drug Administration approved the diabetes-drug Ozempic to be used to help kidney-disease patients. Ozempic, or semaglutide, can now be used to reduce the risk of ...

Novo Nordisk's success with Ozempic in diabetes and kidney disease patients isn't enough for investors Novo estimates that CKD affects some 37 million adults in the U.S., with that number likely ...

which demonstrated a 24% relative risk reduction in kidney disease, kidney failure, and cardiovascular death in patients treated with Ozempic. The FDA has approved Novo Nordisk’s Ozempic (semaglutide) ...

March is National Kidney Month ... MD is a paid Novo Nordisk, Inc. spokesperson. Only Novo Nordisk manufactures FDA-approved semaglutide medicines, like Ozempic®. If the label doesn’t ...

The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

The Food and Drug Administration approved Novo Nordisk's Ozempic for patients with both chronic kidney disease and diabetes, expanding the use of the wildly popular injection in the U.S. The FDA's ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, also known as semaglutide, has been approved to reduce the risk of kidney disease worsening, kidney failure, and death from ...

The FDA's decision means Ozempic can now be used to reduce ... American adults are living with chronic kidney disease, according to Novo Nordisk. Get top local stories delivered to you every ...